SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-17-002977
Filing Date
2017-07-19
Accepted
2017-07-19 12:07:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 IMMUNOCELLULAR THERAPEUTICS, LTD. p17-1526sc13g.htm SC 13G 81647
  Complete submission text file 0000902664-17-002977.txt   83456
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Subject) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59139 | Film No.: 17971879
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G